AMORPHIGENIN

ID: ALA465552

Max Phase: Preclinical

Molecular Formula: C23H22O7

Molecular Weight: 410.42

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Amorphigenin
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C=C(CO)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1

    Standard InChI:  InChI=1S/C23H22O7/c1-11(9-24)16-7-14-15(29-16)5-4-12-22(25)21-13-6-18(26-2)19(27-3)8-17(13)28-10-20(21)30-23(12)14/h4-6,8,16,20-21,24H,1,7,9-10H2,2-3H3/t16-,20-,21+/m1/s1

    Standard InChI Key:  ZJMLELXRQUXRIU-HBGVWJBISA-N

    Associated Targets(Human)

    TE-671 161 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    RPMI-7951 420 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    A549 127892 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HCT-8 3484 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    KB 17409 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Raji 5516 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Lu1 576 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    LNCaP 8286 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    MCF7 126967 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    P388 20296 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 410.42Molecular Weight (Monoisotopic): 410.1366AlogP: 2.68#Rotatable Bonds: 4
    Polar Surface Area: 83.45Molecular Species: NEUTRALHBA: 7HBD: 1
    #RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 13.95CX Basic pKa: CX LogP: 2.04CX LogD: 2.04
    Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.78Np Likeness Score: 1.95

    References

    1. Chin YW, Mdee LK, Mbwambo ZH, Mi Q, Chai HB, Cragg GM, Swanson SM, Kinghorn AD..  (2006)  Prenylated flavonoids from the root bark of Berchemia discolor, a Tanzanian medicinal plant.,  69  (11): [PMID:17125241] [10.1021/np060418w]
    2. Konoshima T, Terada H, Kokumai M, Kozuka M, Tokuda H, Estes JR, Li L, Wang HK, Lee KH..  (1993)  Studies on inhibitors of skin tumor promotion, XII. Rotenoids from Amorpha fruticosa.,  56  (6): [PMID:8350086] [10.1021/np50096a006]
    3. Li L, Wang HK, Chang JJ, McPhail AT, McPhail DR, Terada H, Konoshima T, Kokumai M, Kozuka M, Estes JR..  (1993)  Antitumor agents, 138. Rotenoids and isoflavones as cytotoxic constitutents from Amorpha fruticosa.,  56  (5): [PMID:8326318] [10.1021/np50095a005]
    4. Russell DA, Bridges HR, Serreli R, Kidd SL, Mateu N, Osberger TJ, Sore HF, Hirst J, Spring DR..  (2020)  Hydroxylated Rotenoids Selectively Inhibit the Proliferation of Prostate Cancer Cells.,  83  (6): [PMID:32459967] [10.1021/acs.jnatprod.9b01224]

    Source